Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|June 24, 2004
Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular diseaseEdward J RebarScience (New York, N.Y.)|February 4, 1994
Zinc finger phage: affinity selection of fingers with new DNA-binding specificitiesE J Rebar, C O PaboBiochemical Pharmacology|September 6, 2002
Designed transcription factors as tools for therapeutics and functional genomicsFyodor D Urnov, Edward J RebarApplied Optics|September 1, 1985
Optical distortions and birefringence in high power laser windows: model and computer codeC E Greninger, G A Needham, J RebarEMBO Reports|July 9, 2002
Designed transcription factors as structural, functional and therapeutic probes of chromatin in vivo. Fourth in review series on chromatin dynamicsFyodor D Urnov, Edward J Rebar, Andreas Reik, et al.EMBO Molecular Medicine|February 26, 2014
Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutationsPayam A Gammage, Joanna Rorbach, Anna I Vincent, et al.Genes & Development|January 10, 2002
PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesisDelin Ren, Trevor N Collingwood, Edward J Rebar, et al.Nature Reviews. Genetics|August 19, 2010
Genome editing with engineered zinc finger nucleasesFyodor D Urnov, Edward J Rebar, Michael C Holmes, et al.Methods in Molecular Biology (Clifton, N.J.)|August 4, 2010
A rapid and general assay for monitoring endogenous gene modificationDmitry Y Guschin, Adam J Waite, George E Katibah, et al.The Journal of Biological Chemistry|March 26, 2002
Activation of vascular endothelial growth factor A transcription in tumorigenic glioblastoma cell lines by an enhancer with cell type-specific DNase I accessibilityYuxin Liang, Xiao-Yong Li, Edward J Rebar, et al.Pageof 7